{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:44:14Z","timestamp":1790613854798,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,25]]},"DOI":"10.7759\/cureus.30660","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T10:38:34Z","timestamp":1666694314000},"source":"Crossref","is-referenced-by-count":2,"title":["Inhaled Antibiotics in Non-cystic Fibrosis Bronchiectasis (NCFB): A Systematic Review of Efficacy and Limitations in Adult Patients"],"prefix":"10.7759","author":[{"given":"Zainab","family":"Amjad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Abaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Advait M","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Sadhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hameeda","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma","family":"Nwankwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahvish","family":"Anam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinkhala","family":"Maharjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Sri","family":"Penumetcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0651","article-title":"Diagnosis and management of non-cystic fibrosis bronchiectasis","volume":"21","author":"Macfarlane L","year":"2021","unstructured":"Macfarlane L, Kumar K, Scoones T, Jones A, Loebinger MR, Lord R. Diagnosis and management of non-cystic fibrosis bronchiectasis. Clin Med. 2021, 21:571-7. 10.7861\/clinmed.2021-0651","journal-title":"Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1259\/bjro.20210026","article-title":"Imaging in non-cystic fibrosis bronchiectasis and current limitations","volume":"3","author":"Ledda RE","year":"2021","unstructured":"Ledda RE, Balbi M, Milone F, Ciuni A, Silva M, Sverzellati N, Milanese G. Imaging in non-cystic fibrosis bronchiectasis and current limitations. BJR Open. 2021, 3:20210026. 10.1259\/bjro.20210026","journal-title":"BJR Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0120-2019","article-title":"The radiological diagnosis of bronchiectasis: what's in a name?","volume":"29","author":"Tiddens HA","year":"2020","unstructured":"Tiddens HA, Meerburg JJ, van der Eerden MM, Ciet P. The radiological diagnosis of bronchiectasis: what's in a name?. Eur Respir Rev. 2020, 29:190120. 10.1183\/16000617.0120-2019","journal-title":"Eur Respir Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00162-2017","article-title":"Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis","volume":"4","author":"Woo TE","year":"2018","unstructured":"Woo TE, Lim R, Surette MG, et al.. Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis. ERJ Open Res. 2018, 4:00162-2017. 10.1183\/23120541.00162-2017","journal-title":"ERJ Open Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0630-8","article-title":"Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis","volume":"18","author":"Sch\u00e4fer J","year":"2018","unstructured":"Sch\u00e4fer J, Griese M, Chandrasekaran R, Chotirmall SH, Hartl D. Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis. BMC Pulm Med. 2018, 18:79. 10.1186\/s12890-018-0630-8","journal-title":"BMC Pulm Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.868435","article-title":"Impacts of nontuberculous mycobacteria isolates in non-cystic fibrosis bronchiectasis: a 16-year cohort study in Taiwan","volume":"13","author":"Lin CY","year":"2022","unstructured":"Lin CY, Huang HY, Hsieh MH, et al.. Impacts of nontuberculous mycobacteria isolates in non-cystic fibrosis bronchiectasis: a 16-year cohort study in Taiwan. Front Microbiol. 2022, 13:868435. 10.3389\/fmicb.2022.868435","journal-title":"Front Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1753466620936866","article-title":"Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis","volume":"14","author":"Xu MJ","year":"2020","unstructured":"Xu MJ, Dai B. Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis. Ther Adv Respir Dis. 2020, 14:1753466620936866. 10.1177\/1753466620936866","journal-title":"Ther Adv Respir Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1479972316661923","article-title":"Antibiotic therapy for stable non-CF bronchiectasis in adults: a systematic review","volume":"14","author":"Fjaellegaard K","year":"2017","unstructured":"Fjaellegaard K, Sin MD, Browatzki A, Ulrik CS. Antibiotic therapy for stable non-CF bronchiectasis in adults: a systematic review. Chronic Respir Dis. 2017, 14:174-86. 10.1177\/1479972316661923","journal-title":"Chronic Respir Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11020275","article-title":"Safety and efficacy of devices delivering inhaled antibiotics among adults with non-cystic fibrosis bronchiectasis: a systematic review and a network meta-analysis","volume":"11","author":"Tejada S","year":"2022","unstructured":"Tejada S, Ram\u00edrez-Estrada S, Forero CG, et al.. Safety and efficacy of devices delivering inhaled antibiotics among adults with non-cystic fibrosis bronchiectasis: a systematic review and a network meta-analysis. Antibiotics (Basel). 2022, 11:275. 10.3390\/antibiotics11020275","journal-title":"Antibiotics (Basel)"},{"key":"ref10","article-title":"Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials","volume":"12","author":"Aller SP","year":"2018","unstructured":"Aller SP, Quittner AL, Salathe MA, Schmid A. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials. Expert Rev Respir Med. 2018, 12:769-82.","journal-title":"Expert Rev Respir Med"},{"key":"ref11","article-title":"Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital","volume":"73","author":"Altenburg J","year":"2015","unstructured":"Altenburg J, Wortel K, van der Werf TS, Boersma WG. Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital. Neth J Med. 2015, 73:147-54.","journal-title":"Neth J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00607-2021","article-title":"Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis","volume":"8","author":"Jung F","year":"2022","unstructured":"Jung F, Riley L, Lascano J. Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis. ERJ Open Res. 2022, 8:00607-2021. 10.1183\/23120541.00607-2021","journal-title":"ERJ Open Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072317","article-title":"Inhaled dry powder antibiotics in patients with non-cystic fibrosis bronchiectasis: efficacy and safety in a real-life study","volume":"9","author":"Mart\u00ednez-Garc\u00eda M\u00c1","year":"2020","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, Oscullo G, Barreiro E, et al.. Inhaled dry powder antibiotics in patients with non-cystic fibrosis bronchiectasis: efficacy and safety in a real-life study. J Clin Med. 2020, 9:2317. 10.3390\/jcm9072317","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1479973119872513","article-title":"Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis","volume":"16","author":"Blanco-Aparicio M","year":"2019","unstructured":"Blanco-Aparicio M, Saleta Canosa JL, Vali\u00f1o L\u00f3pez P, Mart\u00edn Ega\u00f1a MT, Vidal Garc\u00eda I, Montero Mart\u00ednez C. Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis. Chronic Respir Dis. 2019, 16:1479973119872513. 10.1177\/1479973119872513","journal-title":"Chronic Respir Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000486134","article-title":"A prospective trial of nebulized amikacin in the treatment of bronchiectasis exacerbation","volume":"95","author":"Ailiyaer Y","year":"2018","unstructured":"Ailiyaer Y, Wang X, Zhang Y, Li C, Li T, Qi Q, Li Y. A prospective trial of nebulized amikacin in the treatment of bronchiectasis exacerbation. Respiration. 2018, 95:327-33. 10.1159\/000486134","journal-title":"Respiration"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02053-2017","article-title":"RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"Aksamit T","year":"2018","unstructured":"Aksamit T, De Soyza A, Bandel TJ, et al.. RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J. 2018, 51:1702053. 10.1183\/13993003.02053-2017","journal-title":"Eur Respir J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000438490","article-title":"Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"90","author":"Orriols R","year":"2015","unstructured":"Orriols R, Hernando R, Ferrer A, Terradas S, Montoro B. Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respiration. 2015, 90:299-305. 10.1159\/000438490","journal-title":"Respiration"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02052-2017","article-title":"RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"De Soyza A","year":"2018","unstructured":"De Soyza A, Aksamit T, Bandel TJ, et al.. RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J. 2018, 51:1702052. 10.1183\/13993003.02052-2017","journal-title":"Eur Respir J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203207","article-title":"Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial","volume":"68","author":"Serisier DJ","year":"2013","unstructured":"Serisier DJ, Bilton D, De Soyza A, et al.. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax. 2013, 68:812-7. 10.1136\/thoraxjnl-2013-203207","journal-title":"Thorax"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00071312","article-title":"Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study","volume":"41","author":"Wilson R","year":"2013","unstructured":"Wilson R, Welte T, Polverino E, et al.. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study. Eur Respir J. 2013, 41:1107-15. 10.1183\/09031936.00071312","journal-title":"Eur Respir J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British Thoracic Society Guideline for bronchiectasis in adults","volume":"74","author":"Hill AT","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD, et al.. British Thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019, 74:1-69. 10.1136\/thoraxjnl-2018-212463","journal-title":"Thorax"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S168014","article-title":"Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis","volume":"12","author":"Chorepsima S","year":"2018","unstructured":"Chorepsima S, Kechagias KS, Kalimeris G, Triarides NA, Falagas ME. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis. Drug Des Dev Ther. 2018, 12:4059-66. 10.2147\/DDDT.S168014","journal-title":"Drug Des Dev Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane PJ","year":"2013","unstructured":"McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013, 188:647-56. 10.1164\/rccm.201303-0411CI","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/110217-inhaled-antibiotics-in-non-cystic-fibrosis-bronchiectasis-ncfb-a-systematic-review-of-efficacy-and-limitations-in-adult-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:25Z","timestamp":1707507805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/110217-inhaled-antibiotics-in-non-cystic-fibrosis-bronchiectasis-ncfb-a-systematic-review-of-efficacy-and-limitations-in-adult-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.30660","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,25]]}}}